Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Automated Quantification of Extranuclear ERα using Phosphor-integrated Dots for Predicting Endocrine Therapy Resistance in HR+/HER2- Breast Cancer.
Guo Z, Tada H, Kitamura N, Hamada Y, Miyashita M, Harada-Shoji N, Sato A, Hamanaka Y, Tsuboi K, Harada N, Takano-Kasuya M, Okada H, Nakano Y, Ohuchi N, Hayashi SI, Ishida T, Gonda K. Guo Z, et al. Cancers (Basel). 2019 Apr 12;11(4):526. doi: 10.3390/cancers11040526. Cancers (Basel). 2019. PMID: 31013810 Free PMC article.
Targeting Amino Acid Metabolic Reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer.
Shindo H, Harada-Shoji N, Ebata A, Sato M, Soga T, Miyashita M, Tada H, Kawai M, Kosaka S, Onuki K, Usami S, Furumoto S, Hayashi S, Abe T, Suzuki T, Ishida T, Sasano H. Shindo H, et al. Among authors: harada shoji n. Cancers (Basel). 2021 Aug 30;13(17):4375. doi: 10.3390/cancers13174375. Cancers (Basel). 2021. PMID: 34503187 Free PMC article.
Bird's eye view analysis of in situ cholesterol metabolic pathways in breast cancer patients and its clinicopathological significance in their subtypes.
Kosaka S, Miyashita M, McNamala K, Nomura M, Shima H, Kawai M, Sato I, Harada-Shoji N, Ishida T, Choi MH, Sasano H. Kosaka S, et al. Among authors: harada shoji n. J Steroid Biochem Mol Biol. 2022 Jul;221:106103. doi: 10.1016/j.jsbmb.2022.106103. Epub 2022 Mar 31. J Steroid Biochem Mol Biol. 2022. PMID: 35367370
Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma.
Nakagawa S, Miyashita M, Maeda I, Goda A, Tada H, Amari M, Kojima Y, Tsugawa K, Ohi Y, Sagara Y, Sato M, Ebata A, Harada-Shoji N, Suzuki T, Nakanishi M, Ohta T, Ishida T. Nakagawa S, et al. Among authors: harada shoji n. Breast Cancer Res Treat. 2024 Apr;204(3):453-463. doi: 10.1007/s10549-023-07209-2. Epub 2024 Jan 5. Breast Cancer Res Treat. 2024. PMID: 38180699 Free PMC article.
20 results